A total of 4.4 million doses will be delivered to us during 2020-21, but only at public vaccination centers. You will not go to private providers or pharmacies.

Coronavirus: the second wave, the second closure

Later than expected by many, but in mid-November, the Hungarian government also decided to try to curb the second wave of the coronavirus epidemic by introducing restrictions. At the time of the decision, 5,000 new infections had been identified per day and the number of deaths from the virus mostly ranged from 50 to 100 in 24 hours. The first step is a partial closure, but how effective it is is questionable. Follow our news!

This year, another 80,000 doses of Pfizer vaccines will arrive in Hungary, and for 2020-2021, Hungary will receive a total of 4.4 million doses of vaccines, said Pfizer Gyógyszerkereskedelmi Kft. At Monday’s online press conference.

According to Krisztina Zsigmond, director of the company’s vaccine business, Pfizer will distribute 50 million doses of the coronavirus vaccine developed jointly with BioNTech by the end of this year and 1.3 billion doses by the end of 2021. The European Commission has linked 200 million vaccines under the EU treaty and you have the option of 100 million additional doses.

The vaccine kit will be distributed under government delivery agreements, and the vaccine will not be distributed to private providers or pharmacies, and will only be available at designated vaccination centers, he said.

Tamás Fabó, Pfizer’s Chief Medical Officer in Hungary, spoke about the fact that clinical trials showed 95% efficiency in vaccinates (this was also mentioned earlier by the rector of Semmelweis University). Half of the 43,000 people in the studies received placebo, half were vaccinated and 162 people in the first group contracted the infection, eight of those in the vaccine group. Studies also showed that the vaccine’s effectiveness was 91 percent in those 65 and older. However, it is not yet possible to say how long the vaccine will provide protection (this may become evident in months). According to Fabó, those vaccinated are followed for two years.

Péter Vereckei, Managing Director of Pfizer Gyógyszerkereskedelmi Kft., Said that one of the great advantages of developing a vaccine based on so-called mRNA technology is that it can respond to changing viral variations in a relatively short time, which is why the new vaccine it can occur in up to six weeks. The essence of the technology is that a part of the virus’s RNA, or hereditary material, is introduced into human cells and the cells produce a harmless virus protein in this form, which, however, triggers the immune response necessary to kill the virus. virus.

Regarding the “mutation of the virus in England”, Péter Vereckei indicated that the vaccine did not yet need to be modified.

The research and development of mRNA technology is named after the biochemist Katalin Karikó, who lives in the United States and has been dealing with this technology for thirty years, and her first patent was registered in 2005.

Calling the development of the vaccine a breakthrough, the CEO said it was a very important moment in the life of the company as “there has never been a more urgent need for the vaccine.” The development of the vaccine has been transparent at all times and the partial results have been published and shared with authorities, he said.

According to Krisztina Zsigmond, Pfizer has developed its own insulated shipping boxes for the safe transportation of the vaccine. The vaccine can be safely stored in the refrigerator for another five days after thawing, he said.



The number of independent power editorial boards is steadily declining, and those that still exist are trying to stay afloat in a growing headwind. At HVG we persevere, we do not give in to pressure and we bring national and international news every day.

That is why we ask you, our readers, to stand by us, support us, join our membership and renew it!

And we promise to keep doing our best for you in all circumstances!

In months, you can find out how long the Pfizer and BioNTech vaccines will protect you



hvg.hu
Technology

Experts from Pfizer Hungary spoke at a press event about the effectiveness, safety and delivery difficulties of the company’s coronavirus vaccine.

Coronavirus vaccine arrives late in eight EU countries



hvg.hu
World

There were logistical problems with the delivery of the Pfizer-BioNTech vaccine to Spain and eight other states. In Italy, meanwhile, the amount received in the first round is decreasing. According to Pfizer, the 200 million doses of vaccines requested will be shipped by the end of September.